"Truvada has been approved by the FDA for HIV prophylaxis" is at http://exm.nr/MryjIY

"Truvada has been approved by the FDA for HIV prophylaxis" is at http://exm.nr/MryjIY

HIV prophylaxis... if a patient refuses HIV testing after a healthcare worker has a needle stick injury.... do not test the patient and go ahead and place the healthcare worker on HIV prophylaxis

HIV prophylaxis... if a patient refuses HIV testing after a healthcare worker has a needle stick injury.... do not test the patient and go ahead and place the healthcare worker on HIV prophylaxis

Pre-exposure prophylaxis #PrEP has been making headlines. But the messages aren't always clear. Get the facts in this video https://docs.google.com/a/prda.asia/spreadsheet/ccc?key=0Ap0eDHBEs_KwdHJSM3JHdUVqR0o3UzVVZGR0LXhfdEE&usp=drive_web#gid=0

Pre-exposure prophylaxis #PrEP has been making headlines. But the messages aren't always clear. Get the facts in this video https://docs.google.com/a/prda.asia/spreadsheet/ccc?key=0Ap0eDHBEs_KwdHJSM3JHdUVqR0o3UzVVZGR0LXhfdEE&usp=drive_web#gid=0

Infographics | Campaign Materials | Start Talking. Stop HIV. | Campaigns | Act Against AIDS | CDC
pin 4
heart 1
Practical and easy-to-understand information for young African women interested in using Pre-exposure prophylaxis (PrEP) to prevent HIV. Check it out!

Practical and easy-to-understand information for young African women interested in using Pre-exposure prophylaxis (PrEP) to prevent HIV. Check it out!

Infographics | Campaign Materials | Start Talking. Stop HIV. | Campaigns | Act Against AIDS | CDC

Infographics | Campaign Materials | Start Talking. Stop HIV. | Campaigns | Act Against AIDS | CDC

pin 7
heart 1
Research suggests that HIV pre-exposure prophylaxis (PrEP) may reduce the risk of HIV in gay men by 82-86% if taken just before and just after sex.

Research suggests that HIV pre-exposure prophylaxis (PrEP) may reduce the risk of HIV in gay men by 82-86% if taken just before and just after sex.

pin 1
heart 1
HIV prophylaxis::: if the source patient has a high CD4 count and a low viral load, then 2 nucleoside reverse transcriptase inhibitors are used for 4 weeks... if the source patient had a high viral load and low CD4 count, then 2 nucleoside reverse transcriptase inhibitors + 1 protease inhibitor is used for 4 weeks

HIV prophylaxis::: if the source patient has a high CD4 count and a low viral load, then 2 nucleoside reverse transcriptase inhibitors are used for 4 weeks... if the source patient had a high viral load and low CD4 count, then 2 nucleoside reverse transcriptase inhibitors + 1 protease inhibitor is used for 4 weeks

Pinterest • The world’s catalogue of ideas
Search